These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19097359)

  • 1. [Galectins in squamous cell carcinomas of the head and neck cancers].
    Cada Z; Plzák J; Chovanec M; Dvoránková B; Lacina L; Szabó P; Smetana K; Betka J
    Cas Lek Cesk; 2008; 147(11):559-63. PubMed ID: 19097359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of new diagnostic markers in pathology by focus on growth-regulatory endogenous lectins. The case study of galectin-7 in squamous epithelia.
    Chovanec M; Smetana K; Plzák J; Betka J; Plzáková Z; Stork J; Hrdlicková E; Kuwabara I; Dvoránková B; Liu FT; Kaltner H; André S; Gabius HJ
    Prague Med Rep; 2005; 106(2):209-16. PubMed ID: 16315769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of galectins in head and neck squamous cell carcinoma.
    Gillenwater A; Xu XC; el-Naggar AK; Clayman GL; Lotan R
    Head Neck; 1996; 18(5):422-32. PubMed ID: 8864733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality.
    Betka J; Plzák J; Smetana K; Gabius HJ
    Acta Otolaryngol; 2003 Jan; 123(2):261-3. PubMed ID: 12701754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.
    Saussez S; Camby I; Toubeau G; Kiss R
    Head Neck; 2007 Sep; 29(9):874-84. PubMed ID: 17315170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
    Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
    Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of molecular markers in the management of head and neck cancers.
    Ferreira MB; De Souza JA; Cohen EE
    Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.
    Plzák J; Betka J; Smetana K; Chovanec M; Kaltner H; André S; Kodet R; Gabius HJ
    Eur J Cancer; 2004 Oct; 40(15):2324-30. PubMed ID: 15454259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microarray - a high-throughput molecular analysis in head and neck cancer.
    Radhakrishnan R; Solomon M; Satyamoorthy K; Martin LE; Lingen MW
    J Oral Pathol Med; 2008 Mar; 37(3):166-76. PubMed ID: 18251941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of interleukin-1 in human squamous carcinomas of the head and neck.
    Ahn JM; Huang CC; Cho HT
    Laryngoscope; 1993 May; 103(5):529-32. PubMed ID: 8483370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary re: Q-T Le et al, identification of osteopontin as a prognostic marker for head and neck squamous cell carcinomas. clin cancer res, 9: 31-32, 2003.
    Denhardt DT
    Clin Cancer Res; 2003 Jan; 9(1):31-2. PubMed ID: 12538448
    [No Abstract]   [Full Text] [Related]  

  • 14. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stem cell hypothesis in head and neck cancer.
    Graziano A; d'Aquino R; Tirino V; Desiderio V; Rossi A; Pirozzi G
    J Cell Biochem; 2008 Feb; 103(2):408-12. PubMed ID: 17546610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.
    Lee KD; Lee HS; Jeon CH
    Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current trends and future prospects in biological markers in squamous cell carcinoma of the head and neck].
    Erdamar B; Süoğlu Y; Kiyak E
    Kulak Burun Bogaz Ihtis Derg; 2002; 9(4):301-3. PubMed ID: 12422088
    [No Abstract]   [Full Text] [Related]  

  • 18. CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck.
    Gires O; Mack B; Rauch J; Matthias C
    Biochem Biophys Res Commun; 2006 Apr; 343(1):252-9. PubMed ID: 16540085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of squamous cell carcinoma of the head and neck.
    Wrangle JM; Khuri FR
    Curr Opin Oncol; 2007 May; 19(3):180-7. PubMed ID: 17414634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varied expression and localization of multiple galectins in different cancer cell lines.
    Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
    Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.